Biosimulation Market Is Expected To Reach worth 2,107.99 Million USD by 2020

The report “Biosimulation Market by Product (Software, Molecular Modeling, PB/PK, PKPD, Trial Design, Toxicity Prediction, In-house, Contract Service), by Application (Drug Discovery & Development, Preclinical, Clinical Trial), by End Users - Global Forecast to 2020”, the biosimulation market is expected to reach USD 2,107.99 Million by 2020 from USD 1,034.93 Million in 2015, growing at a CAGR of 15.29% between 2015 and 2020.

Browse 75 market data tables and 64 figures spread through 150 pages and in-depth TOC on “Biosimulation Market
Early buyers will receive 10% customization on this report.

Biosimulation refers to the computer-aided simulation of biological processes and systems, an integral part of systems biology used in drug discovery and development. Biosimulation is used by researchers and biotechnology and pharmaceutical companies for drug discovery and development.

A strong trend of R&D investments in biotechnology and pharmaceutical industries will majorly drive the biosimulation market. Furthermore, factors such as the need to curtail the drug discovery & development cost, technological advancements such as quantitative systems pharmacology and periodic product upgradation will drive the growth of the biosimulation market.

Get The PDF Brochure:

The application segments of biosimulation will be important revenue pockets during the forecast period (2015–2020). By application, the market is divided into drug discovery, drug development, and other applications (defense, industrial bioprocessing, nutraceuticals, and agri-food production).

The drug development segment is expected to account for the largest share of the biosimulation market in 2015, while the other applications segment is expected to grow at the highest rate. The emerging applications of biosimulation in defense, industrial bioprocessing, nutraceuticals, and agri-food production present significant opportunities for the growth of the global biosimulation market.

North America is expected to account for the largest share of the global biosimulation market in 2015. However, the European market is expected to grow at the highest rate during the forecast period. The growing focus on research-related funding by governments will support innovation and technological advancements in the healthcare sector. This is expected to assist drug discovery and development by pharmaceutical and biotechnology industries and thereby drive the demand for biosimulation. Furthermore, according to the WIPO, Europe accounted for 3,822 pharmaceutical and 1,998 biotechnology patents granted in 2012. Strong growth trends in pharmaceutical and biotechnology industries will aid the growth of the biosimulation market in this region.

Talk To Our Research Analysts for More Information:

Major players in the global biosimulation market are Certara USA, Inc. (U.S.), Simulation Plus Inc. (U.S.), Dassault Systèmes SA (France), Schrödinger Inc. (U.S.), Advanced Chemistry Development, Inc. (Canada), Chemical Computing Group, Inc. (Canada), Physiomics PLC (U.K.), Entelos Holding Corporation (U.S.), Rhenovia Pharma Ltd. (France), and Genedata AG (Switzerland).

Browse Related Reports:
Bioinformatics Market
by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Segment (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 2020.

Healthcare/Medical Simulation Market by Product (Patient Simulator, Surgical Simulator, Web-based simulation, Simulation Software, Dental Simulator, Eye Simulator), End-User (Academics, Hospitals, Military) & by Services - Global Forecast to 2019.

About MarketsandMarkets:
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Subscribe Reports from Healthcare Domain @

Mr. Rohan

Unit No. 802, 8th Floor,
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune – 411013,
Maharashtra, India.
Tel: +1-888-6006-441.
Visit MarketsandMarkets Blog @
Connect with us on LinkedIn @